Rheumatology
Conference Coverage
Patient perspective improves dry eye syndrome research
WASHINGTON –
Daily News Podcast
MDedge Daily News: Doctors say no to pot for sleep apnea
And what’s the best antithrombotic therapy after TAVI?
From the Journals
MACE risk similar across arthritis subtypes
The older age of patients with rheumatoid arthritis explained most of their elevated risk of major adverse cardiovascular events.
From the Journals
SLE: Specialized lupus clinics may offer superior quality of care
“Providing quality care in SLE is challenging as patients require ongoing, time consuming, multidisciplinary care.”
Conference Coverage
Dermatology practice gaps: improving medication management
KAUAI, HAWAII – Ophthalmologists’ hydroxychloroquine dosing recommendations to avoid retinopathy have changed.
From the Journals
Mixed outcomes in analysis of NSAIDs and IBD exacerbation
A meta-analysis and systematic review have found an increased risk of some inflammatory bowel disease with NSAID use, but the studies showed...
Latest News
AbbVie, Samsung Bioepis settle suits with delayed U.S. entry for adalimumab biosimilar
Anti-TNF alpha antibody biosimilar will enter European markets this year, but won’t be in United States until 2023.
From the Journals
Reassurance for women taking certolizumab during pregnancy
Exposure to certolizumab pegol does not appear to be associated with an increased risk of fetal death or congenital malformations.
Daily News Podcast
MDedge Daily News: Could gut bacteria trigger lupus?
And acid suppressors in infancy could fuel allergies later on.
Daily News Podcast
MDedge Daily News: Does more marijuana mean fewer opioids?
And acutely ill patients may not get enough venous thromboembolism prophylaxis.
From the Journals
Most PsA patients discontinue initial biologic within 12 months
The results “suggest a high frequency of suboptimal biologic experience in patients with PsA.”